Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Profound Medical (PROF) Share-based Compensation (IS) (2019 - 2024)

Profound Medical has reported Share-based Compensation (IS) over the past 6 years, most recently at $356000.0 for Q3 2024.

  • For Q3 2024, Share-based Compensation (IS) fell 51.03% year-over-year to $356000.0; the TTM value through Sep 2024 reached $2.9 million, down 22.89%, while the annual FY2020 figure was $3.0 million, 138.39% up from the prior year.
  • Share-based Compensation (IS) for Q3 2024 was $356000.0 at Profound Medical, down from $842000.0 in the prior quarter.
  • Over five years, Share-based Compensation (IS) peaked at $3.0 million in Q4 2020 and troughed at $356000.0 in Q3 2024.
  • A 5-year average of $1.1 million and a median of $941000.0 in 2023 define the central range for Share-based Compensation (IS).
  • Biggest five-year swings in Share-based Compensation (IS): surged 731.21% in 2020 and later tumbled 51.03% in 2024.
  • Year by year, Share-based Compensation (IS) stood at $3.0 million in 2020, then tumbled by 33.93% to $2.0 million in 2021, then tumbled by 39.47% to $1.2 million in 2022, then tumbled by 39.77% to $727000.0 in 2023, then crashed by 51.03% to $356000.0 in 2024.
  • Business Quant data shows Share-based Compensation (IS) for PROF at $356000.0 in Q3 2024, $842000.0 in Q2 2024, and $941000.0 in Q1 2024.